Haddadin Yezan Munther
Outlook Therapeutics, Inc. · Director
Haddadin Yezan Munther is listed in public filings as director. This Haddadin Yezan Munther insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Outlook Therapeutics, Inc. (OTLK). Investors use Haddadin Yezan Munther's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $55k66.2k shares | BuyJun 2, 2026 | $24.1K29k shares | $0.8326 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $16k37.2k shares | BuyMay 26, 2026 | $15.0K34k shares | $0.44 | -- | |
| $102k96k shares | Grant / ExerciseOct 3, 2025 | $101.7K96k shares | $1.06 | -- | |
| $298k286.7k shares | Grant / ExerciseOct 1, 2025 | $298.2K286.7k shares | $1.04 | -- | |
| $104k19.8k shares | Grant / ExerciseOct 3, 2024 | $103.8K19.8k shares | $5.25 | -- | |
| $691k132.3k shares | Grant / ExerciseOct 1, 2024 | $690.6K132.3k shares | $5.22 | -- | |
| $296k56.6k shares | Grant / ExerciseOct 1, 2024 | $295.6K56.6k shares | $5.22 | -- |